Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: Antagonism of the effects of clozapine by modafinil

British Journal of Pharmacology

Volumn 128, Issue 5, 1999, Pages 1055-1063

  Sebban, C ^a   Tesolin Decros, B ^a   Millan, M J ^b   Spedding, M ^c  

^a HÔPITAL CHARLES FOIX   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Clozapine; EEG; Modafinil; Prefrontal cortex; Rat; Risperidone; Sensorimotor cortex; Thalamus

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; AMISULPRIDE; APOMORPHINE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; LEVOMEPROMAZINE; MODAFINIL; NEUROLEPTIC AGENT; QUETIAPINE; RACLOPRIDE; RISPERIDONE; SERTINDOLE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG ANTAGONISM; ELECTROENCEPHALOGRAM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CLOZAPINE; DOPAMINE AGONISTS; ELECTROENCEPHALOGRAPHY; INJECTIONS, SUBCUTANEOUS; MALE; MOTOR CORTEX; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SOMATOSENSORY CORTEX;

EID: 0032712296     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702893     Document Type: Article

References (56)

1. AGHAJANIAN, G.K. & MARFK, G.J. (1997). Serotonin induces excitatory post-synaptic potentials in apical dendrites of neocorticul pyramidal cells. Neuropharmacology, 36, 589-599.
2. 2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res., 825, 161-171.
3. ANDREASEN, N.C. (1994). The mechanisms of schizophrenia. Curr. Opin. Neurobiol., 4, 245-251.
4. ANDREASEN, N.C., REZAI, K., ALLIGER, R., SWAYZE, H. V.W., FLAUM, M., KIRCHNER, P., COHEN, G. & O'LEARY, D.S. (1992). Hypofrontality in neuropleptic-naive patients and in patients with chronic schizophrenia. Arch. Gen. Psych., 49, 943-948.
5. BASTUJI, H.T. & JOUVET, M. (1988). Successful treatment of idiopathic insomnia and narcolepsy with modafinil. Progr. Neuropsychopharmacol. Biol. Psychiat., 12, 695-700.
6. BILLIARD, M., BESSET, A., MONTPLAISIR, J., LAFFONT, F., GOOLDENBERG, F., WEIL, J.S. & LUBIN, S. (1994). Modafinil: a double blind multicentric study. Sleep, 17, S107-S112.
7. BILLIARD, M. & CARLANDER, B. (1998). Troubles de l'éveil: première partie (troubles primaires de l'éveil). Rev. Neurol., 154, 111-129.
8. 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur. J. Neurosci., 6, 293-298.
9. BREIER, A., BUCHANAN, R.W., WALTRIP, H, R.W., LISTWAK, S., HOLMES, C. & GOLDSTEIN, D.S. (1994). The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology, 10, 1-7.
10. 1 adrenergic stimulation in relation to behaviour stimulating effect of modafinil; studies with experimental animals. Eur. J. Pharmacol., 180, 49-58.
11. EGAN, M.F., DUNCAN, C.C., SUDDATH, R.L., KIRCH, D.G., MIRSKY, A.F. & WYATT, R.J. (1994). Event-related potential abnormalities correlate with structural brain alterations ansc linial features in patients with chronic schizophrenia. Schizoph. Res., 11, 259-271.
12. FUNKE, K., PAPE, H.C. & EYSEL, U.T. (1993). Noradrenergic modulation of retinogeniculate transmission in the cat. J. Physiol., 463, 169-191.
13. GAILLARD, J.M. (1990). Neurotransmitters and sleep pharmacology. In Thorpy M.J. (ed.). Handbook of sleep disorders. Marcel Dekker: New York, pp. 55-76.
14. GEVINS, A., CUTILLO, B. & SMITH, M.E. (1995). Regional modulation of high resolution evoked potentials during verbal and non-verbal matching tasks. Electroenceph. Clin. Neurophysiol., 94, 129-147.
15. GOBERT, A., RIVET, J.M., AUDINOT, V., NEWMAN-TANCREDI, A., CISTARELLI, L. & MILLAN, M.J. (1998). Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialyses of freely-moving rats reveals a complex pattern of reciprocal auto-and heteroreceptor-mediated control of release. Neuroscience, 84, 413-429.
16. HERMANN, W.M., SCHARER, E., WENDT, G. & DELINA-STULA, A. (1991). Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry, 24, 214-224.
17. JACOB, H. & BECKMANN, H. (1994). Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. J. Neural. Trans., 98, 83-106.
18. KLIMESCH, W. (1999). EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res. Rev., 29, 169-195.
19. KLIMESCH, W., DOPPELMAYR, M., SCHWAIGER, J., AUINGER, P. & WINKLER, T. (1999). 'Paradoxical' alpha synchronisation in a memory task. Cognitive Brain Res., 7, 493-501.
20. 1 adrenergic psychostimulant, on the sleep of rhesus monkeys. Sleep, 13, 441-448.
21. LIN, J.S., ROUSSEL, B., AKAOKA, H., FORT, P., DEBILLY, G. & JOUVET, M. (1992). Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res., 591, 319-326.
22. LYONS, T.J. & FRENCH, J. (1991). Modafinil: the unique properties of a new stimulant. Aviat. Space Environ. Med., 62, 432-435.
23. MAGISTRETTI, P.J., PELLERIN, L. & MARTIN, J.L. (1995). Brain energy metabolism: an integrated cellular perspective. In Bloom, F.E. & Kupfer, D.J. (eds.). Psychopharmacology, the Fourth Generation of Progress, Raven Press: New York, pp. 657-670.
24. MAR, C.M., SMITH, D.A. & SARTER, M. (1996). Behavioural vigilance in schizophrenia: evidence for hyperattentional processing. Br. J. Psychiatr., 169, 781-789.
25. 1-adrenoceptor activation induces spontaneous excitatory post-synaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur. J. Pharmacol., (in press).
26. MATSUURA, M., YOSHINO, M., OHTA, K., ONDA, H., NAKAJIMA, K. & KOJIMA, T. (1994). Clinical significance of diffuse delta EEG activity in chronic schizophrenia. Clin. Electroencephahgr., 25, 115-121.
27. MCCORMICK, D.A. (1992). Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus. J. Neurosci., 12, 278-289.
28. MIGNOT, E., GUILLEMINAULT, C., BOWERSOX, S., RAPPAPORT, A. & DEMENT, W.C. (1988). Effect of alpha-1 adrenoreceptor blockade with prazosin in canine narcolepsy. Brain Res., 444, 184-188.
29. 1A agonist properties: functional profile in comparison to clozapine and haloperidol. J. Pharmacol. Exp. Ther., 286, 1356-1373.
30. MOLNAR, Z. & BLAKEMORE, C. (1995). How do thalamic neurones find their way to the cortex? Trends Neurosci., 18, 389-397.
31. O'LEARY, D.S., ANDREASEN, N.C., HURTIG, R.R., KESLER, M.L., ROGERS, M., ARNDT, S., CIZADLO, T., WATKINS, G.L., BOLES PONTO, L.L., KIRCHNER, P.T. & HICHWA, R.D. (1996). Auditory attentional deficits in patients with schizophrenia; a positron emission tomography study. Arch. Gen. Psychiatr., 53, 633-641.
32. 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J. Neurosci., 14, 4252-4268.
33. POSNER, M.I. (1997). Neuroimaging of cognitive processes. Cognit. Psychol., 33, 2-4.
34. RAMBERT, F.A., PESSONNIER, J. & DUTEIL, J. (1990). Modafinil-, amphetamine-and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur. J. Pharmacol., 183, 455-456.
35. 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. Eur. J. Pharmacol., 205, 11-16.
36. RUGG, M.D., MARK, R.E., WALLA, P. & SCHLOERSCHEIDT, A.M. (1998). Dissociation of the neural correlates of implicit and explicit memory. Nature, 392, 595-598.
37. SALETU, B., FREY, R., KRUPKA, M., ANDERER, P., GRUNBERGER, J. & BARBANOJ, M.J. (1989). Differential effects of a new central adrenergic agonist modafinil and D-amphetamine on sleep and early morning behaviour in young healthy volunteers. Int. J. Clin. Pharmacol. Res., 9, 183-195.
38. SALETU, B., KUFFERLE, B., GRUNBERGER, J., FOLDES, P., TOPITZ, A. & ANDERER, P. (1994). Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine. Neuropsychobiology, 29, 125-135.
39. SARNTHEIN, J., PETSCHE, H., RAPPELSBERGER, P., SHAW, G.L. & VON STEIN, A. (1998). Synchronization between prefrontal and posterior association cortex during human working memory. Proc. Natl. Acad. Sci. U.S.A.. 95, 7092-7096.
40. SCHOTTE, A., JANSSEN, P.F.M., MEGENS, A.A.H.P. & LEYSEN, J.E. (1993). Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res., 631, 191-202.
41. SEBBAN, C., TESOLIN, B., SHVALOFF, A., LE ROCH, K. & BERTHAUX, P. (1987). Age-related variation of EEG responses to clonidine, praosin and yohimbine in rats. Med. Biol., 65, 255-260.
42. SEBBAN, C., ZHANG, X.Q., TESOLIN-DECROS, B., MILLAN, M.J., amp; SPEDDING, M. (1999). Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br. J. Pharmacol., (in press).
43. SHVALOFF, A., TESOLIN, B. & SEBBAN, C. (1988). Effects of apomorphine in quantified electroencephalography in the frontal cortex: changes with dose and time. Neuropharmacology, 27, 1313-1317.
44. STERIADE, M., AMZICA, F. & NUNEZ, A. (1993a). Cholinergic and noradrenergic modulation of the slow (≈ 0.3 Hz) oscillation in neocortical cells. J. Neurophysiol., 70, 1385-1400.
45. STERIADE, M. & CONTRERAS, D. (1995). Relations between cortical and thalamic cellular events during transition from sleep patterns to paroxysmal activity. J. Neurosci., 15, 623-642.
46. STERIADE, M., DATTA, S., PARE, D., OAKSON, G. & DOSSI, R.C. (1990a). Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci., 10, 2541-2559.
47. STERIADE, M., DOSSI, R.C., PARE, D. & OAKSON, G. (1991). Fast oscillation (20-40 Hz) in thalamocortical system and their potentiation by mesopontine cholinergic nuclei in the cat. Neurobiology, 88, 4396-4400.
48. STERIADE, M., GLOUR, P., LLINAS, R.R., SILVA, F.H.L. & MESULAM, M.M. (1990b). Basic mechanism of cerebral rhythmic activities. Electroenephalogr. Clin. Neurophysiol., 76, 481-508.
49. STERIADE, M., MCCORMICK, D.A. & SEJNOWSKI, T.T. (1993b). Thalamocortical oscillations in the sleeping and arousal brain. Science, 262, 679-685.
50. STERIADE, M., NUNEZ, A. & AMZICA, F. (1993c). Intracellular analysis of relations between the slow (< 1 Hz) neocortical oscillation and other sleep rhythms of the electroencephalogram. J. Neurosci., 13, 3266-3283.
51. TASSIN, J.P., TROVERO, F., HERVE, D., BLANC, G. & GLOWINSKI, J. (1992). Biochemical and behavioural consequences of interactions between dopaminergic and noradrenergic systems in rat prefrontal cortex. Neurochem. Int., 20, 225S-230S.
52. VOLZ, H.P., MACKERT, A., FRICK, K. & BUCKER, U. (1994). Difference in semantic information processing in schizophrenics. Pharmacopsychiatry, 27, 59-62.
53. WEINBERGER, D.R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry, 44, 660-669.
54. WEINBERGER, D.R. (1996). On the plausibility of 'the neurodevelopment hypothesis' of schizophrenia. Neuropsychopharmacology, 14, 1S-11S.
55. WHARTON, C.M. & GRAFMAN, J. (1998). Deductive reasoning and the brain. Trends Cognit. Sci., 2, 54-59.
56. YAMAMOTO, J. (1997). Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine. Psychopharmacology, 131, 379-387.